New hope for tough nerve disease: experimental drug riliprubart enters final testing
NCT ID NCT06290128
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study tests a drug called riliprubart in 140 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) that hasn't improved with standard care. Participants receive either riliprubart or a placebo for up to 111 weeks. The main goal is to see if the drug reduces disability scores at 24 and 48 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Riliprubart (a drug given by IV infusion or injection under the skin)
- What this could lead to
- If it works, this could offer a new treatment option for people with CIDP whose disease doesn't improve with current therapies.
- What could go wrong
- This is still an experimental drug. Even though it's in Phase 3, it may not prove more effective than placebo, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alabama Neurology Associates- Site Number : 8400019
Homewood, Alabama, 35209, United States
-
Austin Neuromuscular Center- Site Number : 8400040
Austin, Texas, 78756, United States
-
Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760012
Vitória, Espírito Santo, 29055-450, Brazil
-
Columbia University Irving Medical Center- Site Number : 8400003
New York, New York, 10032, United States
-
Design Neuroscience Center- Site Number : 8400053
Miami Lakes, Florida, 33016, United States
-
Freire Pesquisa Clínica - Belo Horizonte - Rua Piauí- Site Number : 0760016
Belo Horizonte, Minas Gerais, 30150-320, Brazil
-
Henry Ford Hospital- Site Number : 8400025
Detroit, Michigan, 48202, United States
-
Hospital Moinhos de Vento- Site Number : 0760003
Porto Alegre, Rio Grande do Sul, 90035-902, Brazil
-
Hospital Sao Rafael- Site Number : 0760011
Salvador, Estado de Bahia, 41253-190, Brazil
-
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760017
São Paulo, 05403-000, Brazil
-
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760007
Ribeirão Preto, São Paulo, 14049-900, Brazil
-
Hospital for Special Surgery - Site Number : 8400041
New York, New York, 10021, United States
-
IMMUNOe International Research Centers - Centennial- Site Number : 8400049
Centennial, Colorado, 80112, United States
-
Investigational Site Number : 0320001
Buenos Aires, 1015, Argentina
-
Investigational Site Number : 0320002
Buenos Aires, 1181, Argentina
-
Investigational Site Number : 0320003
Buenos Aires, 1221, Argentina
-
Investigational Site Number : 0560001
Leuven, 3000, Belgium
-
Investigational Site Number : 1000001
Pleven, 5800, Bulgaria
-
Investigational Site Number : 1000002
Blagoevgrad, 2700, Bulgaria
-
Investigational Site Number : 1240001
Québec, Quebec, G1E 7G9, Canada
-
Investigational Site Number : 1520001
Santiago, Reg Metropolitana de Santiago, 8380456, Chile
-
Investigational Site Number : 1520002
Santiago, Reg Metropolitana de Santiago, 8207257, Chile
-
Investigational Site Number : 1520003
Lo Barnechea, Reg Metropolitana de Santiago, 7691236, Chile
-
Investigational Site Number : 1560001
Shanghai, 200040, China
-
Investigational Site Number : 1560002
Fuzhou, 350001, China
-
Investigational Site Number : 1560003
Wuhan, 430030, China
-
Investigational Site Number : 1560004
Xi'an, 710038, China
-
Investigational Site Number : 1560005
Beijing, 100053, China
-
Investigational Site Number : 1560006
Wuhan, 430060, China
-
Investigational Site Number : 1560007
Guangzhou, 510080, China
-
Investigational Site Number : 1560008
Jinan, 250014, China
-
Investigational Site Number : 1560009
Changsha, 410008, China
-
Investigational Site Number : 1560010
Beijing, 100050, China
-
Investigational Site Number : 1560011
Chengdu, 610072, China
-
Investigational Site Number : 1560012
Guangzhou, 510000, China
-
Investigational Site Number : 1560013
Beijing, 100034, China
-
Investigational Site Number : 1560014
Hangzhou, 310003, China
-
Investigational Site Number : 1560015
Nanchang, 330006, China
-
Investigational Site Number : 1560016
Beijing, 100730, China
-
Investigational Site Number : 1580001
Taipei, 100, Taiwan
-
Investigational Site Number : 1580002
Taipei, 112, Taiwan
-
Investigational Site Number : 1580003
Kaohsiung City, 833, Taiwan
-
Investigational Site Number : 2030002
Pardubice, 532 03, Czechia
-
Investigational Site Number : 2030003
Hradec Králové, 500 05, Czechia
-
Investigational Site Number : 2030004
Brno, 625 00, Czechia
-
Investigational Site Number : 2080001
Copenhagen, 2100, Denmark
-
Investigational Site Number : 2080002
Aarhus, 8200, Denmark
-
Investigational Site Number : 2500001
Le Kremlin-Bicêtre, 94270, France
-
Investigational Site Number : 2500002
Marseille, 13885, France
-
Investigational Site Number : 2500003
Lille, 59037, France
-
Investigational Site Number : 2500004
Paris, 75013, France
-
Investigational Site Number : 2500005
Montpellier, 34295, France
-
Investigational Site Number : 2760001
Bad Homburg, 61348, Germany
-
Investigational Site Number : 2760003
Giessen, 35392, Germany
-
Investigational Site Number : 2760004
Berlin, 12163, Germany
-
Investigational Site Number : 2760005
Essen, 45147, Germany
-
Investigational Site Number : 2760006
Tübingen, 72076, Germany
-
Investigational Site Number : 2760007
Bochum, 44791, Germany
-
Investigational Site Number : 3000001
Thessaloniki, 546 36, Greece
-
Investigational Site Number : 3000002
Athens, 124 62, Greece
-
Investigational Site Number : 3000003
Larissa, 411 10, Greece
-
Investigational Site Number : 3800001
Milan, Milano, 20132, Italy
-
Investigational Site Number : 3800003
Palermo, 90127, Italy
-
Investigational Site Number : 3800004
Pisa, 56126, Italy
-
Investigational Site Number : 3800005
Pavia, 27100, Italy
-
Investigational Site Number : 3800006
Rome, Roma, 00133, Italy
-
Investigational Site Number : 3800007
Messina, 98125, Italy
-
Investigational Site Number : 3800008
Rome, Roma, 00189, Italy
-
Investigational Site Number : 3800009
Rozzano, Milano, 20089, Italy
-
Investigational Site Number : 3920001
Chiba, 260-8677, Japan
-
Investigational Site Number : 3920003
Fukuoka, 812-8582, Japan
-
Investigational Site Number : 3920005
Kawagoe, Saitama, 350-8550, Japan
-
Investigational Site Number : 3920006
Sayama, Osaka, 589-8511, Japan
-
Investigational Site Number : 3920008
Kodaira, Tokyo, 187-8551, Japan
-
Investigational Site Number : 3920009
Saga, 849-0937, Japan
-
Investigational Site Number : 3920011
Bunkyo-Ku, Tokyo, 113-8510, Japan
-
Investigational Site Number : 3920013
Tokyo, 173-8605, Japan
-
Investigational Site Number : 3920014
Yaizu, Shizuoka, 425-8505, Japan
-
Investigational Site Number : 4100001
Seoul, Seoul-teukbyeolsi, 06351, South Korea
-
Investigational Site Number : 4100003
Seoul, Seoul-teukbyeolsi, 02841, South Korea
-
Investigational Site Number : 4840002
Veracruz, 91900, Mexico
-
Investigational Site Number : 4840003
Guadalajara, Jalisco, 44670, Mexico
-
Investigational Site Number : 4840005
Culiacán, Sinaloa, 80020, Mexico
-
Investigational Site Number : 5280001
Amsterdam, 1105 AZ, Netherlands
-
Investigational Site Number : 5280002
Rotterdam, 3015 CE, Netherlands
-
Investigational Site Number : 6160002
Lublin, Lublin Voivodeship, 20-016, Poland
-
Investigational Site Number : 6160003
Rzeszów, Podkarpackie Voivodeship, 35-055, Poland
-
Investigational Site Number : 6160006
Krakow, Lesser Poland Voivodeship, 31-501, Poland
-
Investigational Site Number : 6200001
Lisbon, 1349-019, Portugal
-
Investigational Site Number : 6200003
Matosinhos Municipality, 4464-513, Portugal
-
Investigational Site Number : 6200004
Lisbon, 1150-199, Portugal
-
Investigational Site Number : 6200005
Coimbra, 3000-075, Portugal
-
Investigational Site Number : 6200006
Lisbon, 1649-035, Portugal
-
Investigational Site Number : 7240001
Barcelona, Catalunya [Cataluña], 08041, Spain
-
Investigational Site Number : 7240002
Valencia, 46026, Spain
-
Investigational Site Number : 7240003
Pamplona, Navarre, 31008, Spain
-
Investigational Site Number : 7240005
Oviedo, Principality of Asturias, 33011, Spain
-
Investigational Site Number : 7240006
Majadahonda, Madrid, 28222, Spain
-
Investigational Site Number : 7240007
Bilbao, Basque Country, 48013, Spain
-
Investigational Site Number : 7240008
Barcelona, Barcelona [Barcelona], 08035, Spain
-
Investigational Site Number : 7240009
Sabadell, 08208, Spain
-
Investigational Site Number : 7240010
Santa Cruz de Tenerife, 38010, Spain
-
Investigational Site Number : 7240012
Santiago de Compostela, A Coruña [La Coruña], 15706, Spain
-
Investigational Site Number : 7520001
Stockholm, 113 65, Sweden
-
Investigational Site Number : 7920001
Istanbul, 34093, Turkey (Türkiye)
-
Investigational Site Number : 7920002
Bursa, 16059, Turkey (Türkiye)
-
Investigational Site Number : 7920003
Konya, 42075, Turkey (Türkiye)
-
Investigational Site Number : 7920004
Istanbul, 34785, Turkey (Türkiye)
-
Investigational Site Number : 7920006
Ankara, 06170, Turkey (Türkiye)
-
Investigational Site Number : 7920007
Ankara, 06620, Turkey (Türkiye)
-
Johns Hopkins Hospital- Site Number : 8400015
Baltimore, Maryland, 21287, United States
-
Massachusetts General Hospital- Site Number : 8400009
Boston, Massachusetts, 02114, United States
-
Michigan State University- Site Number : 8400038
East Lansing, Michigan, 48824, United States
-
NeuroMedical Clinic of Central Louisiana- Site Number : 8400031
Alexandria, Louisiana, 71301, United States
-
NorthShore University Health System - Glenbrook Hospital- Site Number : 8400024
Glenview, Illinois, 60026, United States
-
Nova Clinical Research - Bradenton- Site Number : 8400044
Bradenton, Florida, 34209, United States
-
Ochsner Medical Center - Jefferson Highway- Site Number : 8400030
New Orleans, Louisiana, 70121, United States
-
PSEG Centro de Pesquisa Clínica- Site Number : 0760009
São Paulo, 04038-002, Brazil
-
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022
Philadelphia, Pennsylvania, 19104, United States
-
Penn State Health Milton South Hershey Medical Center- Site Number : 8400042
Hershey, Pennsylvania, 17033, United States
-
Profound Research- Site Number : 8400052
Las Vegas, Nevada, 89106, United States
-
Raleigh Neurology Associates- Site Number : 8400043
Raleigh, North Carolina, 27607, United States
-
USC Norris Comprehensive Cancer Center- Site Number : 8400002
Los Angeles, California, 90033, United States
-
UTHealth - The University of Texas Health Sciences Center at Houston- Site Number : 8400050
Houston, Texas, 77054, United States
-
University Hospitals Cleveland Medical Center- Site Number : 8400033
Cleveland, Ohio, 44106, United States
-
University of California Irvine - Manchester Pavilion- Site Number : 8400007
Orange, California, 92868, United States
-
University of Cincinnati Medical Center- Site Number : 8400020
Cincinnati, Ohio, 45219, United States
-
University of Kansas Medical Center- Site Number : 8400010
Kansas City, Kansas, 66160, United States
-
University of Vermont Medical Center- Site Number : 8400012
Burlington, Vermont, 05401, United States
-
University of Virginia- Site Number : 8400023
Charlottesville, Virginia, 22908, United States
-
Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037
St Louis, Missouri, 63110, United States
-
Yale University School of Medicine- Site Number : 8400018
New Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Can digital tools better track disability in a rare nerve disease? a new study aims to find out.
- New hope for teens with rare nerve disease: drug trial launches
- New nerve patch could ease pain after biopsy
- Blood test may Fine-Tune IVIg dosing for rare nerve disorders
- Engineered immune cells take aim at multiple sclerosis and myasthenia gravis